Sudden cardiac arrest remains one of the leading causes of death in Europe, yet rapid access to a defibrillator can dramatically increase survival rates. Despite this, defibrillators are still absent from many homes, workplaces, and public spaces. Paris based Lifeaz is working to close that gap, and has now secured fresh funding to scale its mission.
Lifeaz has closed a €13 million funding round to support the expansion of its connected defibrillator solutions across Europe. The round includes continued backing from Mutuelles Impact, an investment initiative launched by La Mutualité Française and managed by XAnge in partnership with Impactivist. New investors joining the company include BNP Paribas, GO CAPITAL, and Mirova, an affiliate of Natixis.
Making defibrillators accessible to everyone
Founded in 2015, Lifeaz develops automated external defibrillators designed for use by individuals and businesses without requiring medical expertise. The company focuses on simplicity and accessibility, aiming to reduce hesitation and confusion during emergencies when every second counts.
Lifeaz defibrillators guide users step by step through both visual and audio instructions, enabling even untrained bystanders to act quickly. The devices are built for deployment in a wide range of environments, including private homes, offices, schools, and commercial locations.
Connected technology for reliability and readiness
Beyond the physical device, Lifeaz integrates connected technology to ensure reliability over time. Each defibrillator performs automated self checks to monitor battery status, electrode condition, and overall functionality. This data is transmitted remotely, allowing maintenance issues to be detected and addressed before an emergency occurs.
This approach tackles a common problem in public access defibrillation: devices that are present but non operational due to expired components or lack of oversight. By automating monitoring and maintenance, Lifeaz aims to increase real world readiness rather than simply increasing device numbers.
Training and awareness beyond hardware
Lifeaz positions itself as more than a hardware provider. The company supports defibrillator deployment with training and education tools designed to build confidence among users. A free mobile application offers guidance and educational resources, while in person workshops help businesses and organisations train employees in emergency response.
By combining equipment, connectivity, and education, Lifeaz seeks to address both availability and preparedness, two factors that significantly influence survival outcomes during cardiac arrest events.
Funding to support European expansion
According to Johann Kalchman, Lifeaz’s leadership sees the new funding as a way to accelerate the company’s impact across both private and professional settings. The investment will be used to grow the customer base, expand into additional European markets, and increase organisational capacity.
The company plans to strengthen its teams to support product development, customer service, and regional rollout as it scales operations. Europe wide expansion is a central focus, as awareness around public access defibrillation continues to grow but adoption remains uneven between countries.
Addressing a persistent public health challenge
Cardiac arrest survival rates are strongly linked to early defibrillation, yet access remains limited in many environments where people live and work. Lifeaz’s model reflects a broader shift toward decentralised, connected medical devices that empower citizens rather than relying solely on emergency services.
With this funding round, Lifeaz aims to increase the number of defibrillators deployed, improve their reliability, and ensure more people feel capable of intervening when emergencies occur. As healthcare systems increasingly emphasise prevention and early intervention, the company is positioning itself as a key player in making life saving technology more accessible across Europe.